HOLLY RUTTAN: Open Payments
NPI 1194278705 · LAMBERTVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,497 in 140 payments from 17 companies in 2025. Trend: 2023 $1,690 · 2024 $2,527 · 2025 $2,497
Food & beverage: $2,434Education: $63
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $369 |
| ABBVIE INC. | 26 | $343 |
| UCB, Inc. | 15 | $287 |
| E.R. Squibb & Sons, L.L.C. | 14 | $225 |
| Amgen Inc. | 5 | $188 |
| LEO Pharma Inc. | 9 | $187 |
| GENZYME CORPORATION | 12 | $176 |
| PFIZER INC. | 6 | $171 |
| Organon LLC | 3 | $119 |
| Galderma Laboratories, L.P. | 5 | $89 |
Products named: TREMFYA, Bimzelx, DUPIXENT, Sotyktu, SKYRIZI, OTEZLA, LITFULO, VTAMA.
Industry payments across MI — which companies pay providers there.
